Jump to content
  • Sign Up
Scott Adams

Biolinerx Enters Clinic With Novel Treatment For Celiac Disease - Pr Newswire (Press Release)

Rate this topic

Recommended Posts

BioLineRx Enters Clinic with Novel Treatment for Celiac Disease

PR Newswire (press release)

"The commencement of BL-7010's Phase 1/2 study in a world-leading celiac treatment center is an important milestone in the development of one of our most promising projects," said Dr. Kinneret Savitsky, Chief Executive Officer of BioLineRx. "Based on ...

BioLineRx enrolls first patient in BL-7010 Phase 1/2 trial for treatment of ... News-Medical.net

BioLineRx Enrols First Patient In Phase 1/2 Trial Of BL-7010 NASDAQ

all 6 news articles »

View the full article

Share this post

Link to post
Share on other sites

In 'up to 32 patients'.

Thirty two?????

"The Phase 1/2 study is a two-part (single and repeated), double-blind, placebo-controlled, dose escalation study of BL-7010 in up to 32 patients. The primary objective of the study is to assess the safety of single and repeated ascending doses of BL-7010 in well-controlled celiac patients. Secondary objectives include an assessment of the systemic exposure, if any, of BL-7010 in the study patients."

Share this post

Link to post
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Create New...